Effects of Lomitapide on Carotid and Aortic Atherosclerosis

NCT02399852 · clinicaltrials.gov ↗

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Homozygous Familial Hypercholesterolemia

Interventions

DRUG: Lomitapide

Sponsor

Aegerion Pharmaceuticals, Inc.